Elicio Therapeutics, Inc. (ELTX) Operating income 2020–2025
Elicio Therapeutics, Inc. (ELTX) annual operating income history from SEC filings — each fiscal year as reported.
-$37.7MFY2025 · since FY2020: -$55.3M → -$37.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$37.7M | +16.2% |
| FY2024 | -$45.0M | -25.9% |
| FY2023 | -$35.7M | -50.6% |
| FY2022 | -$23.7M | +39.6% |
| FY2021 | -$39.3M | +28.9% |
| FY2020 | -$55.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice